ENDOCLOT
EndoClot Plus, Inc.
Application Filed: 2011-05-16
Trademark Application Details
SECTION 8-ACCEPTED
| Research |
OneLook
Acronym Finder
|
| Serial Number | 85322084 |
| Registration Number | 4412920 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Law Office Assigned | L80 |
| Employee Name | DAWE III, WILLIAM H |
Timeline
| 2011-05-16 | Application Filed |
| 2011-10-23 | Date of First Use |
| 2012-05-01 | Published for Opposition |
| 2013-10-08 | Trademark Registered |
| 2018-10-31 | Location: TMEG LAW OFFICE 108 |
| 2018-10-31 | Status: Live/Registered |
| 2018-10-31 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  EndoClot Plus, Inc. |
| Address | 5201 Great America Parkway, Suite 526 Santa Clara CA 95054 |
| Legal Entity Type | Corporation |
| Legal Entity State | CA |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 10 |
| U.S. Codes: | 026,039,044 |
| Type Code | Type |
|---|---|
| GS0101 | Medical device, namely, a delivery system for endoscopic application of hemostatic powder to bleeding sites of the wound in the gastrointestinal tract and other human cavities including abdominal cavity, thoracic cavity and uterine cavity |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2011-05-19 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2011-05-20 | 2 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2011-08-31 | 3 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2011-08-31 | 4 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2011-08-31 | 5 GNRT F:First Action |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2011-08-31 | 6 GNRN O:Outgoing Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2012-02-22 | 7 TCCA I:Incoming Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2012-02-22 | 8 TROA I:Incoming Correspondence |
| ASSIGNED TO LIE | 2012-03-12 | 9 ALIE A:Allowance for Publication |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2012-03-19 | 10 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2012-03-19 | 11 TEME I:Incoming Correspondence |
| NON-FINAL ACTION WRITTEN | 2012-03-19 | 12 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2012-03-19 | 13 GNRT O:Outgoing Correspondence |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2012-03-19 | 14 GNRN O:Outgoing Correspondence |
| TEAS AMENDMENT OF USE RECEIVED | 2012-03-20 | 15 EAAU I:Incoming Correspondence |
| USE AMENDMENT FILED | 2012-03-21 | 16 IUAF S: |
| AMENDMENT TO USE PROCESSING COMPLETE | 2012-03-21 | 17 AUPC I:Incoming Correspondence |
| USE AMENDMENT ACCEPTED | 2012-03-22 | 18 IUAA P: |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2012-03-22 | 19 CNSA O:Outgoing Correspondence |
| NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED | 2012-03-23 | 20 AAUA E:E-Mail |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2012-03-24 | 21 PREV O:Outgoing Correspondence |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2012-04-11 | 22 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2012-05-01 | 23 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2012-05-01 | 24 NPUB E:E-Mail |
| EXTENSION OF TIME TO OPPOSE RECEIVED | 2012-05-18 | 25 ETOF T:TTAB Proceeding |
| OPPOSITION INSTITUTED NO. 999999 | 2012-08-28 | 26 OP.I T:TTAB Proceeding |
| OPPOSITION DISMISSED NO. 999999 | 2013-09-02 | 27 OP.D T:TTAB Proceeding |
| OPPOSITION TERMINATED NO. 999999 | 2013-09-02 | 28 OP.T T:TTAB Proceeding |
| TTAB RELEASE CASE TO TRADEMARKS | 2013-09-02 | 29 TMBN T:TTAB Proceeding |
| REGISTERED-PRINCIPAL REGISTER | 2013-10-08 | 30 R.PR A:Allowance for Publication |
| COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | 2018-10-08 | 31 REM1 E:E-Mail |
| TEAS SECTION 8 RECEIVED | 2018-10-29 | 32 ES8R I:Incoming Correspondence |
| CASE ASSIGNED TO POST REGISTRATION PARALEGAL | 2018-10-31 | 33 APRE A:Allowance for Publication |
| REGISTERED - SEC. 8 (6-YR) ACCEPTED | 2018-10-31 | 34 8.OK O:Outgoing Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2018-10-29 | 35 TCCA I:Incoming Correspondence |
| NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED | 2018-10-31 | 36 NAS8 E:E-Mail |
| COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | 2022-10-08 | 37 REM2 E:E-Mail |
| TEAS SECTION 8 & 9 RECEIVED | 2023-04-04 | 38 E89R I:Incoming Correspondence |
| CASE ASSIGNED TO POST REGISTRATION PARALEGAL | 2023-10-05 | 39 APRE A:Allowance for Publication |
| REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | 2023-10-05 | 40 89AG O:Outgoing Correspondence |
| REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) | 2023-10-05 | 41 RNL1 Q: |
| NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED | 2023-10-05 | 42 NA89 E:E-Mail |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 ENDOCLOT 97292080 not registered Live/Pending |
EndoClot Plus, Inc. 2022-03-02 |
 ENDOCLOT 85322084 4412920 Live/Registered |
EndoClot Plus, Inc. 2011-05-16 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 